Patent ID: 7781183
Filing Date: 2010-08-24
Classification: C12Q,G01N,G16B,G16C

Abstract:
1. A method of inhibiting anthrax lethal factor protease activity which comprises contacting at least one compound selected from the group consisting of denoted as NSC 341911, denoted as NSC 294206, denoted as NSC 300509, denoted as NSC 294494, denoted as NSC 359465, denoted as NSC 354962, denoted as NSC 377362, denoted as NSC 317881, denoted as NSC 317884, denoted as NSC 354961, denoted as NSC 12155, denoted as NSC 317880, denoted as NSC 317886, denoted as NSC 294200, denoted as NSC 294203, denoted as NSC 341909, denoted as NSC 357756, denoted as NSC 369718, denoted as NSC 369721, denoted as NSC 294201, denoted as NSC 290107, denoted as NSC 294204, denoted as NSC 240898, and denoted as NSC 266474 with anthrax lethal factor protease.